Tenderloin Drug Dealer Sentenced to 46 Months for Fentanyl Sales
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Tenderloin Drug Dealer Sentenced to 46 Months for Fentanyl Sales

Tenderloin Drug Dealer Sentenced to 46 Months for Fentanyl Sales

June 09, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Akilah Johnson
Phone Number: (415) 436-7994

SAN FRANCISCO – Emil Arriola Melendez was sentenced in federal court today to 46 months in prison for the distribution of fentanyl, announced United States Attorney Stephanie M. Hinds and Drug Enforcement Administration (DEA) Special Agent in Charge Wade R. Shannon.  Senior United States District Judge Maxine M. Chesney handed down the sentence.

Melendez, 33, of South San Francisco, pleaded guilty on March 18, 2022, to distributing fentanyl. In his plea agreement, Melendez admitted that in September and November 2021 he exchanged numerous text messages with an undercover law enforcement officer posing as a drug buyer.  Melendez arranged through the messages to sell fentanyl and heroin to the undercover officer.  On September 22, 2021, near Geary and Hyde Streets in San Francisco’s Tenderloin area, Melendez met and sold the undercover officer 110 grams of fentanyl for $3,000.  Melendez further admitted that on October 27, 2021, he again met with the undercover officer near Geary and Hyde Streets and sold the officer 227 grams (approximately eight ounces) of fentanyl and 56 grams (approximately two ounces) of heroin.  Melendez charged the officer $7,800.

In its sentencing memo, the government described that the investigation of Melendez began when three individuals in Trinity County in the rural north of California (population: 12,541) died from fentanyl overdoses in a single weekend in August 2021.  The dealer who sold fentanyl to the decedents before their overdoses was arrested.  That dealer identified Melendez as a source of fentanyl supply and said that he would drive to meet and buy fentanyl from Melendez in the San Francisco Bay Area and then return with the fentanyl to Trinity and Shasta Counties.  This information led to the undercover officer being introduced to Melendez and Melendez’s sales to the officer.

During the search of Melendez’s home at the time of his arrest, law enforcement located a privately made firearm (a PMF, or “ghost gun”).  As part of the sentence, the firearm was forfeited.

In addition to the 46 month federal prison term, Senior U.S. District Judge Maxine M. Chesney ordered Melendez to serve three years of supervised release following his release from prison.  Melendez was in custody at his sentencing hearing and begins serving his sentence immediately. 

Assistant U.S. Attorney Joseph Tartakovsky prosecuted the case with the assistance of Mark DiCenzo.  The prosecution is the result of an investigation by DEA, the U.S. Bureau of Land Management, the Trinity County Sheriff’s Office, the Shasta Interagency Narcotics Task Force, and the North State Major Investigation Team.

Fentanyl, a Schedule II controlled substance, is a highly potent opioid that can be diluted with cutting agents to create counterfeit pills that purport to mimic the effects of Oxycodone and can typically be obtained at a lower cost than genuine Oxycodone.  Counterfeit fentanyl-laced pills are commonly shaped and colored to resemble Oxycodone pills sold legitimately in the marketplace. Counterfeit pills known as M30s are round tablets that are often light blue, but can vary in color, and have “M” and “30” imprinted on opposite sides of the pill. Small variations in the amount or quality of fentanyl can have significant effects on the potency of the counterfeit pills, drastically raising the danger of overdoses.  Fentanyl recently became the leading cause of drug overdose deaths throughout the United States.

Download Press Release
###
Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Bob P. Beris, Special Agent in Charge - San Francisco
@DEASanFrancisco
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español